Title List مقالات لاتين Petrology of combeite- and götzenite-bearing nephelinite at Nyiragongo, Virunga Volcanic Province in the East African Rift Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug

بر اساس عنوان

1

Petrology of combeite- and götzenite-bearing nephelinite at Nyiragongo, Virunga Volcanic Province in the East African Rift

2

Petrology of eclogites from north of Shahrekord, Sanandaj-Sirjan Zone, Iran

3

Petrology of Gilbody, Pennington and Christian/Pennington (18th Century Liverpool) Porcelains and their Distinction from some Contemporary Phosphatic and Magnesian/Plombian British Wares

4

Petrology of highly aluminous xenoliths from kimberlites of Yakutia

5

Petrology of high-Mg, low-Ti igneous rocks of the Glenelg River Complex (SE Australia) and the nature of their interaction with crustal melts

6

Petrology of HP metamorphic veins in coesite-bearing eclogite from western Tianshan, China: Fluid processes and elemental mobility during exhumation in a cold subduction zone

7

Petrology of hypabyssal kimberlites: Relevance to primary magma compositions

8

Petrology of Indus River sands: a key to interpret erosion history of the Western Himalayan Syntaxis

9

Petrology of iron-rich magmatic segregations associated with strongly peraluminous trondhjemite in the Cornucopia stock, northeastern Oregon

10

Petrology of kamafugites and kimberlites from the Alto Paranaíba Alkaline Province, Minas Gerais, Brazil

11

Petrology of Lasail plutonic complex, northern Oman ophiolite, Oman: An example of arc-like magmatism associated with ophiolite detachment

12

Petrology of mafic and ultramafic intrusions from the Portneuf–Mauricie Domain, Grenville Province, Canada: Implications for plutonic complexes in a Proterozoic island arc

13

Petrology of mafic and ultramafic layered rocks from the Jaboncillo Valley, Sierra de Valle Fértil, Argentina: Implications for the evolution of magmas in the lower crust of the Famatinian arc

14

Petrology of mafic lavas within the Onega plateau, central Karelia: evidence for 2.0 Ga plume-related continental crustal growth in the Baltic Shield

15

Petrology of melilite-bearing rocks from the Montefiascone Volcanic Complex (Roman Magmatic Province): new insights into the ultrapotassic volcanism of Central Italy

16

Petrology of Nile River sands (Ethiopia and Sudan): Sediment budgets and erosion patterns

17

Petrology of Ocellar Lamprophyres in South Delhi Fold Belt, Danva, Sirohi District, Rajasthan, India

18

Petrology of rocks formed by interaction of mafic magmas and high-grade metamorphic rocks at Suya Taco area, northern Sierra de Comechingones, Argentina

19

Petrology of sapphirine granulite and associated sodic gneisses from the Indian Head Range, Newfoundland

20

Petrology of spinel peridotite xenoliths from northeastern Brazil: lithosphere with a high geothermal gradient imparted by Fernando de Noronha plume

21

Petrology of the 1991–1995 eruption at Unzen: effusion pulsation and groundmass crystallization

22

Petrology of the 1998–2000 products of Volcán de Colima, México

23

Petrology of the Basic Granulites from Kodaikanal, South India

24

Petrology of the Betulia Igneous Complex, Cauca, Colombia

25

Petrology of the bimodal Cenozoic volcanism of the Kapsiki plateau (northernmost Cameroon, Central Africa)

26

Petrology of the Cenozoic volcanism in the Upper Benue valley, northern Cameroon (Central Africa)

27

Petrology of the Coyaguayma ignimbrite, northern Puna of Argentina: Origin and evolution of a peraluminous high-SiO2 rhyolite magma

28

Petrology of the Easter microplate region in the South Pacific

29

Petrology of the eclogites from western Tasmania: Insights into the Cambro-Ordovician evolution of the paleo-Pacific margin of Gondwana

30

Petrology of the granitoid intrusions in the Shalair Valley area, northeastern Iraq

31

Petrology of the Hegenshan ophiolite and its implication for the tectonic evolution of northern China

32

Petrology of the hypabyssal kimberlite of the Kroonstad group II kimberlite (orangeite) cluster, South Africa: Evolution of the magma within the cluster

33

PETROLOGY OF THE INJANA FORMATION (UPPER MIOCENE)AT ZAWITA, AMADIYA AND ZAKHO AREA, NORTHERN IRAQ

34

Petrology of the Luingo caldera (SE margin of the Puna plateau): A middle Miocene window of the arc–back arc configuration

35

Petrology of the Mesoarchean Rio Maria suite and the discrimination of sanukitoid series

36

Petrology of the Miocene igneous rocks in the Altar region, main Cordillera of San Juan, Argentina. A geodynamic model within the context of the Andean flat-slab segment and metallogenesis

37

Petrology of the Mio-Pliocene volcanism to the North and East of Ngaoundéré (Adamawa, Cameroon)

38

Petrology of the most recent ultrapotassic magmas from the Roman Province (Central Italy)

39

Petrology of the Namib Sand Sea: Long-distance transport and compositional variability in the wind-displaced Orange Delta

40

Petrology of the Nohi Rhyolite and its related granitoids: A Late Cretaceous large silicic igneous field in central Japan

41

Petrology of the Precambrian Mafic Rocks of Katekalyan Area, Bastar District, Madhya Pradesh, India

42

Petrology of the Rabaul Caldera area, Papua New Guinea

43

Petrology of the Renard igneous bodies: host rocks for diamond in the northern Otish Mountains region, Quebec

44

Petrology of titanian clinohumite and olivine at the high-pressure breakdown of antigorite serpentinite to chlorite harzburgite (Almirez Massif, S. Spain)

45

Petrology of two continental alkaline intraplate series at Emi Koussi volcano, Tibesti, Chad

46

Petrology of two diamondiferous eclogite xenoliths from the Lahtojoki kimberlite pipe, eastern Finland

47

Petrology of ultrahigh-pressure eclogites from the ZK703 drillhole in the Donghai, eastern China

48

Petrology of ultramafic lamprophyres from the Beaver Lake area of Eastern Antarctica and their relation to the breakup of Gondwanaland

49

Petrology of ultramafic xenoliths in Cenozoic alkaline rocks of northern Madagascar (Nosy Be Archipelago)

50

Petrology of volcanic products younger than 42 ka on the Lipari–Vulcano complex (Aeolian Islands, Italy): an example of volcanism controlled by tectonics

51

Petrology, geochemistry and genesis of rift-related carbonatites of Ambadungar, India

52

Petrology, geochemistry and geodynamic implications of Jurassic island arc magmatism as revealed by mafic volcanic rocks in the Mesozoic low-grade sequence, eastern Rhodope, Bulgaria

53

Petrology, geochemistry and geodynamic setting of Proterozoic igneous suites of the Orَs fold belt (Borborema Province, Northeast Brazil)

54

Petrology, geochemistry and isotopic ages of eclogites from the Dulan UHPM Terrane, the North Qaidam, NW China

55

Petrology, geochemistry and paleomagnetism of the earliest magmatic rocks of Deccan Volcanic Province, Kutch, Northwest India

56

Petrology, geochemistry and ReOs isotopes of peridotite xenoliths from Maguan, Yunnan Province: Implications for the Cenozoic mantle replacement in southwestern China

57

Petrology, geochemistry and Re–Os isotopes of peridotite xenoliths from Yantai, Shandong Province: Evidence for Phanerozoic lithospheric mantle beneath eastern North China Craton

58

Petrology, geochemistry and Sr–Nd isotopes of the Trindade and Martin Vaz volcanic rocks (Southern Atlantic Ocean)

59

Petrology, geochemistry and Sr–Nd–Pb isotopes of the volcanic rocks from Pico Island—Azores (Portugal)

60

Petrology, geochemistry and tectonic setting intrusive massives of Baft ophiolitic – melange, Southeast of Kerman, Iran

61

Petrology, geochemistry and tectonic significance of Palaeoproterozoic alkaline lamprophyres from the Jungel Valley, Mahakoshal supracrustal belt, Central India

62

PETROLOGY, GEOCHEMISTRY AND TECTONICAL ENVIRONMENT OF THE SHALAIR METAMORPHIC ROCK GROUP AND KATAR RASH VOLCANIC GROUP, SHALAIR VALLY AREA, NORTHEASTERN IRAQ

63

Petrology, Geochemistry and Tectonomagmatic Evolution of Hezar Igneous Complex (Rayen- South of Kerman- Iran): the First Description of an Arc Remnant of the Neotethyan Subduction Zone

64

Petrology, geochemistry and U–Pb geochronology of the Betic Ophiolites: Inferences for Pangaea break-up and birth of the westernmost Tethys Ocean

65

Petrology, geochemistry and zircon U–Pb and Lu–Hf isotopes of the Cretaceous dykes in the central North China Craton: Implications for magma genesis and gold metallogeny

66

Petrology, geochemistry, and geochronology of Paleoproterozoic volcanic and granitic rocks (1.89–1.88 Ga) of the Pitinga Province, Amazonian Craton, Brazil

67

Petrology, geochemistry, and geochronology of the post-collisional Triassic mangerite and syenite in the Gwangcheon area, Hongseong Belt, South Korea

68

Petrology, geochemistry, and geochronology of trondhjemites from the Qori Complex, Neyriz, Iran

69

Petrology, geochemistry, and Na metasomatism of Triassic-Jurassic non-marine clastic sediments in the Newark, Hartford, and Deerfield rift basins, northeastern USA

70

Petrology, geochemistry, and petrogenesis of mafic dykes from the Kermanshah Ophiolite in Sahneh-Harsin area of Western Iran

71

Petrology, Geochemistry, Petrogenesis and Reactivation of Volcanic Tuffs at Dair El-Kahif Area, NE-Jordan

72

Petrology, geochemistry, S, Cl and F abundances, and S oxidation state of sideromelane glass shards from Pleistocene ash layers north and south of Gran Canaria (ODP Leg 157)

73

Petrology, geochronology and Sr–Nd isotopic geochemistry of the Konso pluton, south-western Ethiopia: implications for transition from convergence to extension in the Mozambique Belt

74

Petrology, isotope geochemistry and chemical budgets of oceanic gabbros-seawater interactions in the Equatorial Atlantic

75

Petrology, major and trace element geochemistry, geochronology, and isotopic composition of granitic intrusions from the vicinity of the Bosumtwi impact crater, Ghana

76

Petrology, mineral and isotope geochemistry of the Sondalo gabbroic complex (Central Alps, Northern Italy): implications for the origin of post-Variscan magmatism

77

Petrology, mineral chemistry and Sr–Nd–Pb isotopic compositions of granitoids in the central Menderes metamorphic core complex: Constraints on the evolution of Aegean lithosphere slab

78

Petrology, mineral chemistry, and exploration significance of Fe-sulfides from the metal dispersion halo surrounding the Cadjebut Znsingle bondPb MVT deposit, Western Australia

79

Petrology, Mineralogy and Diagenesis of the Rus and Jil Formations (l- Eocene) in Najif and Samawa areas, Southern Iraq

80

Petrology, mineralogy and geochemistry of oxide minerals in polymict xenoliths from the Bultfontein kimberlites, South Africa: implication for low bulk-rock oxygen isotopic ratios

81

Petrology, Origin and Metamorphic History of Proterozoic-aged Granulites of the Natal Metamorphic Province, Southeastern Africa

82

Petrology, structural setting, timing, and geochemistry of Cretaceous volcanic rocks in eastern Mongolia: Constraints on their tectonic origin

83

Petrology, structure and tectonic significance of the Tuclame banded schists in the Sierras Pampeanas of Cَrdoba and its relationship with the metamorphic basement of northwestern Argentina

84

Petrol—something nasty in the woodshed? A review of gasoline-related burns in a British burns unit

85

Petromagnetic characteristics of Cameroon Line volcanic rocks

86

PETROMAP: MS-DOS software package for quantitative processing of X-ray maps of zoned minerals

87

Petro-mineralogy and geochemistry as tools of provenance analysis on archaeological pottery: Study of Inka Period ceramics from Paria, Bolivia

88

Petronella Clarke

89

Petrophysical analysis of limestone rocks by nuclear logging and 3D high-resolution X-ray computed microtomography

90

Petrophysical analysis of limestone rocks by nuclear logging and 3D high-resolution X-ray computed microtomography

91

Petrophysical analysis of regional-scale thermal properties for improved simulations of geothermal installations and basin-scale heat and fluid flow

92

Petro-physical Analysis of Well Logs for Reservoir Evaluation: A Case Study of Well 1 and 2 of the ‘Ictorian’ Field in the Niger Delta Basin

93

Petrophysical and consolidation behavior of mass transport deposits from the northern Gulf of Mexico, IODP Expedition 308

94

Petrophysical and durability tests on sandstones for the evaluation of their quality as building stones using Analytical Hierarchy Process (AHP)

95

Petrophysical and rock-mechanics effects of CO2 injection for enhanced oil recovery: Experimental study on chalk from South Arne field, North Sea

96

Petrophysical characterization of Chinese coal cores with heat treatment by nuclear magnetic resonance

97

Petrophysical characterization of coals by low-field nuclear magnetic resonance (NMR)

98

Petrophysical Charaterization of the Kwale Field Reservoir Sands (OML 60) from Wire-line Logs, Niger Delta, Nigeria

99

Petrophysical Constraints on Deformation Styles in Aztec Sandstone, Southern Nevada, USA

100

Petrophysical data for integrated flow modeling

101

Petrophysical data prediction from seismic attributes using committee fuzzy inference system

102

Petrophysical databases for ground characterisation: design concepts and considerations

103

Petrophysical Evaluation of Bangestan Group Formations in an Iranian Oil Field Document Type : Research Paper

104

Petrophysical evaluation of low-resistivity sandstone reservoirs with nuclear magnetic resonance log

105

Petrophysical Evaluation of Reservoir in A Selected Well (Z) in an Onshore Oil Field (X) in the Niger Delta Basin, Nigeria using Wireline Logs

106

Petrophysical Evaluation of Reservoir Sand Bodies in Kwe Field Onshore Eastern Niger Delta

107

Petrophysical laboratory measurements for basin and reservoir evaluation

108

Petrophysical Properties and Reservoir Modeling of Mishrif Formation at Amara Oil Field, Southeast Iraq

109

Petrophysical properties of bioclastic platform carbonates: implications for porosity controls during burial

110

Petrophysical properties of porous medium from Petrographic Image Analysis data

111

Petrophysical Properties of the Kahasib Formation in Missan Region, South Iraq

112

Petros D. Karkos, Spiros P. Potamianos, Maria T. Apostolidis, Giorgios Kekes

113

Petrosal approach: The avenue to the cerebellopontine angle and petrous apex

114

Petrosamine, a potent anticholinesterase pyridoacridine alkaloid from a Thai marine sponge Petrosia n. sp Original Research Article

115

Petrosectomies for invasive tumours: surgery and reconstruction

116

Petrosia testudinaria as a biomarker for metal contamination at Gulf of Mannar, southeast coast of India

117

Petrosiols A–E, neurotrophic diyne tetraols isolated from the Okinawan sponge Petrosia strongylata

118

Petrotectonic evolution of the high- to ultrahigh-pressure Maksyutov Complex, Karayanova area, south Ural Mountains: structural and oxygen isotope constraints

119

Petrotetrayndiol A induces cell cycle arrest and apoptosis in SK-MEL-2 human melanoma cells through cytochrome c-mediated activation of caspases

120

Petrous apicitis in a child: computed tomography and magnetic resonance imaging findings

121

Petrov–Galerkin and discontinuous-Galerkin methods for time-domain and frequency-domain electromagnetic simulations

122

Petrov-Galerkin finite element method for gas-liquid two-phase flow based on an incompressible two-fluid model

123

Petrov-Galerkin finite element method for gas-liquid two-phase flow based on an incompressible two-fluid model

124

Petrov-Galerkin finite element method for gas–liquid two-phase flow based on an incompressible two-fluid model Original Research Article

125

Petrov-Galerkin finite element method for solving the MRLW equation

126

Petrov–Galerkin methods for nonlinear systems without monotonicity Original Research Article

127

PETROV-GALERKIN METHODS FOR THE TRANSIENT ADVECTIVE-DIFFUSIVE EQUATION WITH SHARP GRADIENTS

128

Pets and protein: : placing domestic livestock on hobby-farms in England and Wales

129

PETs and their users: a critical review of the potentials and limitations of the privacy as confidentiality paradigm

130

PETs at CSCL Service: Underutilised Potentials for Privacy Enhancing Distance Education

131

Pets, Maternal Sensitization And Continent Of Ancestry Influence Fetal Ige Production

132

Petschek shocks of reconnection for anisotropic pressure Original Research Article

133

PET-SWNT nanocomposites through ultrasound assisted dissolution-evaporation

134

PET-THERAPY: A TRIAL FOR INSTITUTIONALIZED FRAIL ELDERLY PATIENTS

135

Petua dan Pantang Larang Tradisional dalam Alam Melayu Sarawak

136

Peudoexfoliation and poterior capular opacification

137

Peudoexfoliation in a rural population of outhern India: the Aravind Comprehenive Eye urvey

138

Peudoexfoliation yndrome in Autralian adult

139

Peudohypopyon after intravitreal triamcinolone acetonide injection for cytoid macular edema

140

Peudohypopyon of orange pigment overlying a table choroidal nevu

141

Peudomona aeruginoa in vitro corneal iolate enitivity to ofloxacin, ciprofloxacin, and trovafloxacin: a comparative tudy

142

Peudopapilledema in neurofibromatoi type 2

143

Peumusolide A, unprecedented NES non-antagonistic inhibitor for nuclear export of MEK

144

Peut-on évaluer le rôle de la sédimentation sur lʹeffet de serre à lʹéchelle de temps des cycles orbitaux ?

145

Peut-on respecter les contraintes de doses au niveau du tronc cérébral dans les irradiations des carcinomes nasopharyngés ?

146

Peut-on respecter les contraintes de doses au niveau du tronc cérébral dans les irradiations des carcinomes nasopharyngés ?

147

Peut-on se passer de l’imagerie multimodalités dans la délinéation du lit opératoire des métastases cérébrales ?

148

Peut-on se passer de l’imagerie multimodalités dans la délinéation du lit opératoire des métastases cérébrales ?

149

PEUTZ JEGHERS SYNDROME PRESENTING WITH ACUTE INTESTINAL OBSTRUCTION: A RARE CASE REPORT WITH REVIEW OF LITERATURES

150

PEUTZ-JEGHER SYNDROME CASE REPORT AND REVIEW OF LITERATURE

151

Peutz-Jeghers Syndrome With Diffuse Gastrointestinal Polyposis: Three Cases in a Family With Different Manifestations and No Evidence of Malignancy During 14 Years Follow Up

152

Peutz-Jeghers syndrome without mucocutaneous pigmentation: a case report

153

Peutz-Jeghers syndrome: 78-year follow-up of the original family

154

PeV cosmic rays: a window on the leptonic era?

155

PeV gamma rays from interactions of ultra high energy cosmic rays in the Milky Way

156

PeV scale Left–Right symmetry and baryon asymmetry of the Universe Original Research Article

157

Pexelizumab Reduces Death and Myocardial Infarction in Higher Risk Cardiac Surgical Patients

158

Peyer’s patch-mediated intestinal immune system modulating activity of pectic-type polysaccharide from peel of Citrus unshiu

159

Peygamberimiz Hz. Muhammed’in Müezzinleri

160

Peykan check, a simple continuous quality control method for hematology analyzers

161

Peyronie’s disease: A contemporary review of non-surgical treatment

162

Peyssonols A and B, Two Novel Inhibitors of the Reverse Transcriptases of Human Immunodeficiency Virus Types 1 and 2

163

PF. Barlett, Editor, Urban Place: Reconnecting with the Natural World, The MIT Press, Cambridge, MA (2005) ISBN 0-262-52443-0 (330pp., $24.00).

164

PF1022A — A novel anthelmintic cyclooctadepsipeptide. Modification and exchange of the N-methyl leucine residues

165

PF2401-SF, standardized fraction of Salvia miltiorrhiza and its constituents, tanshinone I, tanshinone IIA, and cryptotanshinone, protect primary cultured rat hepatocytes from bile acid-induced apoptosis by inhibiting JNK phosphorylation

166

PFA — A component in building materials produced from the german plastic packaging waste stream

167

PFA, a Novel Mollusk Agglutinin, Is Structurally Related to the Ribosome-Inactivating Protein Superfamily

168

Pfaffia mosaic virus: a new potyvirus found infecting Pfaffia glomerata in Brazil

169

Pfaffian and Hafnian identities in shuffle algebras

170

Pfaffian decomposition and a Pfaffian analogue of q-Catalan Hankel determinants

171

Pfaffian ideals of ladders Original Research Article

172

Pfaffian Identities: A Combinatorial Approach

173

Pfaffian representation of solutions to a coupled (2 + 1)-dimensional system

174

Pfaffian solution for coupled discrete nonlinear Schrödinger equation

175

Pfaffian solutions for the Manin-Radul-Mathieu SUSY KdV and SUSY sine-Gordon equations

176

Pfaffianization of a -dimensional generalized Kadomtsev–Petviashvili equation

177

Pfaffianization of the two-dimensional Toda lattice

178

Pfaffians and Determinants for SchurQ-Functions

179

Pfaffians, superpotentials and vector bundle moduli

180

Pfaffʹs method (I): The Mills-Robbins-Rumsey determinant Original Research Article

181

Pfaffʹs method (II): diverse applications

182

PFAM catalyzed enantioselective diethylzinc addition to imines

183

Pfanzagl exchanges diagnose an anomaly in expected utility decision theory Original Research Article

184

PFAPA and 12 Common MEFV Gene Mutations Our Clinical Experience

185

PFC full bridge rectifiers EMI modeling and analysis-common mode disturbance reduction

186

PFC Simulation of Brazilian Tensile Strength Test in Geomaterials’ Specimens with T-shaped Non-persistent Joints

187

PFC: A packet forwarding control scheme for vehicle handover over the ITS networks

188

P-FCM: a proximity—based fuzzy clustering

189

P-FCM: a proximity-based fuzzy clustering for user-centered web applications Original Research Article

190

PFCRT and DHFR-TS Sequences for Monitoring Drug Resistance in Adzopé Area of Côte d’Ivoire After the Withdrawal of Chloroquine and Pyrimethamine

191

Pfcrt Gene in Plasmodium falciparum Field Isolates from Muzaffargarh, Pakistan

192

pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective

193

PFEIFFER TYPE I SYNDROME: A GENETICALLY PROVEN CASE REPORT

194

p-FEM applied to finite isotropic hyperelastic bodies Original Research Article

195

p-FEM for finite deformation powder compaction Original Research Article

196

p-FEMs in biomechanics: Bones and arteries

197

PFeW11-doped polymer film modified electrodes and their electrocatalytic activity for H2O2 reduction Original Research Article

198

PFG NMR and internal magnetic field gradients in plant-based materials

199

PFG NMR observation of an extremely strong dependence of the ammonia self-diffusivity on its loading in H-ZSM-5

200

PFG NMR self-diffusion studies of fluid transport and surface-to-volume ratios in sands

201

PFG NMR self-diffusion studies of fluid transport and surface-to-volume ratios in sands

202

PFG NMR tracer exchange measurements of xenon in zeolites

203

PFGE characterisation and adhesion ability of Listeria monocytogenes isolates obtained from bovine carcasses and beef processing facilities

204

PFGE genotyping and antimicrobial susceptibility of Campylobacter in retail poultry meat in Estonia

205

PFGE genotyping and molecular characterization of Campylobacter spp. isolated from chicken meat

206

PFG-NMR approach to determining the water transport mechanism in polymer electrolyte membranes conditioned at different temperatures

207

PFG-NMR self-diffusion in casein dispersions: Effects of probe size and protein aggregate size

208

PFHC: A clustering algorithm based on data partitioning for unevenly distributed datasets

209

Pfiesteria piscicida and Pfiesteria shumwayae in coastal waters of Long Island, New York, USA

210

Pfiesteria: Harmful Algal Blooms as Indicators of Human: Ecosystem Interactions

211

P-filters and hereditary Baire function spaces

212

P-Filters and the perfect set property

213

p-Filtrations and the Steinberg Module

214

Pfisterʹssubform theorem for reduced special groups

215

Pfizer CEOʹs call to action

216

Pfizer Diflucan Partnership Program

217

Pfizer loses sildenafil case in Australia

218

PFKFB3 Promotes Liver Fibrosis by Regulating Aerobic Glycolysis of Hepatic Stellate Cells

219

PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer

220

PFKFB4 as a prognostic marker in non-muscle-invasive bladder cancer

221

Pflanzenphysiologie, P. Schopfer, A. Brennicke. Springer Verlag, Berlin, Heidelberg (1999)

222

PF-MPC: Particle filter-model predictive control

223

PfMyb1, a Plasmodium falciparum Transcription Factor, is Required for Intra-erythrocytic Growth and Controls Key Genes for Cell Cycle Regulation Original Research Article

224

PFOS and PFOA in the livers of harbour porpoises (Phocoena phocoena) stranded or bycaught around the UK

225

p-Fractals and power series–I. Some 2 variable results

226

p-Fractals and power series—II.: Some applications to Hilbert–Kunz theory

227

PFS for Mars Express: A new approach to study Martian atmosphere Original Research Article

228

PFS on Mars Express: preparing the analysis of infrared spectra to be measured by the Planetary Fourier Spectrometer

229

PFS/MEX observations of the condensing CO2 south polar cap of Mars

230

PFS: an effective instrument for the study of martian environment Original Research Article

231

PFS-MEX observation of ices in the residual south polar cap of Mars

232

P-functions, Quasi-convex Functions, and Hadamard-type Inequalities1

233

PG 1613+426: A new sdB pulsator

234

PG&E files U.S. suit to halt destec-modesto-praxair deal

235

PG&E proposes its own retail customer accesss

236

PG&E, SCE sell 10,000 MW in plants above book value

237

pg4DB: A fuzzy object-relational system

238

PGA1 and PGA2 are selective ligands for the EP2 and EP4 prostaglandin receptor subtypes

239

PGAIPG, a Repeated Hexapeptide of Bovine and Human Tropoelastin, Is Chemotactic for Neutrophils and Lewis Lung Carcinoma Cells

240

PGAIPG, a Repeated Hexapeptide of Bovine and Human Tropoelastin, Is Chemotactic for Neutrophils and Lewis Lung Carcinoma Cells

241

PGAMgnam Style: A Glycolytic Switch Controls Biosynthesis

242

PGC-1α is induced by parathyroid hormone and coactivates Nurr1-mediated promoter activity in osteoblasts

243

PGC1-α mRNA expression cross talk with tumor volume growth and total antioxidant capacity in breast cancer model mice: following discontinuous aerobic exercise and vitamin D intake

244

PGD for aneuploidy screening: an expensive hoax?

245

PGE and Os isotopic analyses of single sample aliquots with NiS fire assay preconcentration

246

PGE and Os-isotopic variations in lavas from Kohala Volcano, Hawaii: Constraints on PGE behavior and melt/crust interaction

247

PGE enrichment in chromitite layers and the Merensky Reef of the western Bushveld Complex; a Re¯Os and Rb¯Sr isotope study

248

PGE enrichment in chromitite layers and the Merensky Reef of the western Bushveld Complex; a Re–Os and Rb–Sr isotope study

249

PGE geochemistry and Re–Os dating of massive sulfide ores from the Baimazhai Cu–Ni deposit, Yunnan province, China

250

PGE geochemistry of the Fengshan porphyry–skarn Cu–Mo deposit, Hubei Province, Eastern China

251

PGE mineralization in marginal sulfide ores of the Chineisky layered intrusion, Russia

252

PGE mineralization in the late Archaean iron-rich mafic-ultramafic Hanumalapur Complex, Karnataka, India

253

PGE reefs as an in situ crystallization phenomenon: the Nadezhda gabbronorite body, Lukkulaisvaara layered intrusion, Fennoscandian Shield, Russia

254

PGE Wins Contract to Serve New Palm Springs Muni

255

PGE2 induces oenocytoid cell lysis via a G protein-coupled receptor in the beet armyworm, Spodoptera exigua

256

PGE2 production is suppressed by chemically-synthesized Δ7-eicosatrienoic acid in macrophages through the competitive inhibition of COX-2

257

PGE2 targets squamous cell carcinoma cell with the activated epidermal growth factor receptor family for survival against 5-fluorouracil through NR4A2 induction

258

PGEN: an integrated model of leaf photosynthesis, transpiration, and conductance

259

PGEN: an integrated model of leaf photosynthesis, transpiration, and conductance

260

PGEs and other traffic-related elements in roadside soils from Sa˜o Paulo, Brazil

261

PGHS-2 inhibitors, NS-398 and DuP-697, attenuate the inhibition of PGHS-1 by aspirin and indomethacin without altering its activity

262

P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil

263

P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER).

264

P-glycoprotein activity in renal clear cell carcinoma

265

P-glycoprotein and sister P-glycoprotein sequences from mummichog, Fundulus heteroclitus, liver and intestine

266

P-Glycoprotein expression by human colonic tumor cells influences the growth of tumor cells in vitro

267

P-glycoprotein expression in human major and minor salivary glands

268

P-glycoprotein expression in Perna viridis after exposure to Prorocentrum lima, a dinoflagellate producing DSP toxins

269

P-glycoprotein in autoimmune diseases

270

P-GLYCOPROTEIN IN BLOOD BRAIN BARRIER

271

P-glycoprotein induction: an antidotal pathway for paraquat-induced lung toxicity

272

P-glycoprotein interfering agents potentiate ivermectin susceptibility in ivermectin sensitive and resistant isolates of Teladorsagia circumcincta and Haemonchus contortus

273

P-glycoprotein is downregulated in KG1a-primitive leukemia cells by LDL cholesterol deprivation and by HMG-CoA reductase inhibitors

274

P-glycoprotein is implicated in the inhibition of ceramide-induced apoptosis in TF-1 acute myeloid leukemia cells by modulation of the glucosylceramide synthase pathway

275

P-GLYCOPROTEIN QUANTITATION IN ACUTE LEUKEMIA

276

P-glycoprotein: Its role in drug resistance

277

P-Glycoprotein-Mediated Efflux and Drug Sequestration in Lysosomes Confer Advantages of K562 Multidrug Resistance Sublines to Survive Prolonged Exposure to Cytotoxic Agents

278

P-glycoprotein-mediated efflux of antiepileptic drugs: preliminary studies in mdr1a knockout mice

279

P-glycoproteins are not released into bile

280

PGM beamline with constant energy resolution mode for U49-2 undulator at BESSY-II

281

PGM beamline with constant energy resolution mode for U49-2 undulator at BESSY-II

282

PGO: A parallel computing platform for global optimization based on genetic algorithm

283

Pgp deficiency increases amyloid concetrations in the brain

284

PGP4, an ATP Binding Cassette P-Glycoprotein, Catalyzes Auxin Transport in Arabidopsis thaliana Roots

285

PGPR-induced defense responses in the tea plant against blister blight disease

286

pGPro1, a novel binary vector for monocot promoter characterization

287

PGR5 Is Involved in Cyclic Electron Flow around Photosystem I and Is Essential for Photoprotection in Arabidopsis

288

P-graph methodology for cost-effective reduction of carbon emissions involving fuel cell combined cycles

289

p-groups in the Betti-Mathieu group Original Research Article

290

p-GROUPS OF AUTOMORPHISMS OF ABELIAN p-GROUPS

291

p-Groups of Small Breadth

292

p-GROUPS WITH A SMALL NUMBER OF CHARACTER DEGREES AND THEIR NORMAL SUBGROUPS

293

PGRP-SC2 Promotes Gut Immune Homeostasis to Limit Commensal Dysbiosis and Extend Lifespan

294

PGS and the Critical Decision on Transfer of Defective Embryos

295

PGSE diffusion NMR studies on mononuclear and dinuclear cationic platinum salts of (S)-MeO-Biphep and (R)-p-tolyl-BINAP

296

PGSS-drying: Mechanisms and modeling

297

p-Guanidinoethyl calixarene and parent phenol derivatives exhibiting antibacterial activities. Synthesis and biological evaluation Original Research Article

298

pH – Specific synthesis, spectroscopic, and structural characterization of an assembly of species between Co(II) and N,N-bis(phosphonomethyl)glycine. Gaining insight into metal-ion phosphonate interactions in aqueous Co(II)–organophosphonate systems

299

pH adjustment for seasonal control of UF fouling by natural waters Original Research Article

300

pH Affects the Thermal Inactivation Parameters of R-Phycoerythrin from Porphyra yezoensis

301

pH and biogeochemical processes in the Gotland Basin of the Baltic Sea

302

pH and buffering capacity problems involved in the determination of ammonia in saline water using the indophenol blue spectrophotometric method

303

pH and buffering capacity problems involved in the determination of ammonia in saline water using the indophenol blue spectrophotometric method Original Research Article

304

pH and electro-responsive release behavior of MWCNT/PVA/PAAc composite microcapsules

305

pH- and glucose-sensitive glycopolymer nanoparticles based on phenylboronic acid for triggered release of insulin

306

pH and glutathion-responsive hydrogel for localized delivery of paclitaxel

307

pH and grain-size variation in leaching tests with bricks made of harbour sediments compared to commercial bricks

308

pH and heat-induced structural changes of bovine apo-α-lactalbumin

309

pH and hydrogen peroxide dual responsive supramolecular prodrug system for controlled release of bioactive molecules

310

pH and ionic strength effect on single fibrinogen molecule adsorption on mica studied with AFM

311

pH- and metal-dependent structural diversity from mononuclear to two-dimensional polymers based on a flexible tricarboxylate ligand

312

pH- and mol-ratio dependent formation of zinc(II) coordination polymers with iminodiacetic acid: Synthesis, spectroscopic, crystal structure and thermal studies

313

pH- and mol-ratio dependent tungsten(VI)–citrate speciation from aqueous solutions: syntheses, spectroscopic properties and crystal structures

314

pH and pCO2 microelectrode measurements and the diffusive behavior of carbon dioxide species in coastal marine sediments

315

pH and redox-responsive mixed micelles for enhanced intracellular drug release

316

pH and salt effects on chiral separations using affinity ultrafiltration Original Research Article

317

pH and salt responsive poly(N,N-dimethylaminoethyl methacrylate) cylindrical brushes and their quaternized derivatives

318

pH and salt-induced reversible aggregation of nonionic synthetic glycolipid vesicles

319

pH and solute concentration of suspension media affect the outcome of high hydrostatic pressure treatment of Listeria monocytogenes

320

pH- and sugar-sensitive layer-by-layer films and microcapsules for drug delivery

321

pH and surface tension dependence of mixed sodium deoxycholate–sodium dehydrocholate pre-micellar aggregation in aqueous solution

322

pH and temperature dependence of particle size in Pb1−xFexS nanoparticle films

323

pH and temperature dependent facile precipitation of nano-goethite particles in Fe(NO3)3–NaOH–NH3NH2HSO4–H2O medium

324

pH and temperature responsive porous membranes via an in situ bulk copolymerization approach

325

pH- and temperature-dependent release from cationic vesicles coexisting with copolymer of N-isopropylacrylamide and methacrylic acid

326

pH- and temperature-responsive amphiphilic diblock copolymers of 4-vinylpyridine and oligoethyleneglycol methacrylate synthesized by RAFT polymerization

327

pH- and temperature-responsive hydrogels from crosslinked triblock copolymers prepared via consecutive atom transfer radical polymerizations

328

pH- and temperature-responsive poly(aspartic acid)-l-poly(N-isopropylacrylamide) conetwork hydrogel

329

pH- and temperature-sensitive multiblock copolymer hydrogels composed of poly(ethylene glycol) and poly(amino urethane)

330

pH- and temperature-sensitive permeation through polyelectrolyte complex films composed of chitosan and polyalkyleneoxide–maleic acid copolymer

331

pH- and thermo-multi-responsive fluorescent micelles from block copolymers via reversible addition fragmentation chain transfer (RAFT) polymerization

332

pH- and thermo-responsive microcontainers as potential drug delivery systems: Morphological characteristic, release and cytotoxicity studies

333

pH- and thermosensitive thin lipid layer coated mesoporous magnetic nanoassemblies as a dual drug delivery system towards thermochemotherapy of cancer

334

pH- and time-dependent hemoglobin transitions: A case study for process modelling Original Research Article

335

p–H and T–S diagrams of 3He from 0.2 K to 20 K Original Research Article

336

pH changes in peralkaline late-magmatic fluids

337

pH changes of self-etching primers mixed with powdered dentine

338

pH control for enhanced reductive bioremediation of chlorinated solvent source zones Original Research Article

339

pH control of the structure, composition, and catalytic activity of sulfated zirconia

340

pH control on oxygen isotopic composition of symbiotic corals

341

pH control strategy in astaxanthin fermentation bioprocess by Xanthophyllomyces dendrorhous

342

pH control strategy of batch microbial transglutaminase production with Streptoverticillium mobaraense

343

pH control: handling nonlinearity and deadtime with fuzzy relational model-based control

344

pH controlled condensation of polysiloxane networks at the water–air interface

345

pH Controlled Dispersion of Non-oxide Ceramic Powders in Aqueous Media

346

pH Controlled Dispersion of Non-oxide Ceramic Powders in Aqueous Media

347

pH controlled emission of ruthenium(II)–tris–bipyridine complexes

348

pH controlled selective transport of proteins through charged ultrafilter membranes under coupled driving forces: An efficient process for protein separation

349

pH controlled size/shape in CTAB micelles with solubilized polar additives: A viscometry, scattering and spectral evaluation

350

pH controlled supramolecular structures of new silver(I) complexes based on 2-sulfoterephthalic acid and 4,4′-bipyridine

351

pH controls over anaerobic carbon mineralization, the efficiency of methane production, and methanogenic pathways in peatlands across an ombrotrophic–minerotrophic gradient

352

pH controls over anaerobic carbon mineralization, the efficiency of methane production, and methanogenic pathways in peatlands across an ombrotrophic–minerotrophic gradient

353

pH dependant sticking probability of gold colloid on silicon

354

pH dependence and thermodynamics of Hg(II) adsorption onto chitosan-poly(vinyl alcohol) hydrogel adsorbent

355

pH dependence of electrokinetic behavior of dolomite and magnesite in aqueous electrolyte solutions

356

pH Dependence of ferrous sorption onto two smectite clays

357

pH dependence of heme electrochemistry in cytochromes investigated by multiconformation continuum electrostatic calculations

358

pH Dependence of inhibitors targeting the occluding loop of cathepsin B

359

pH dependence of PDMS–PMAA IPN morphology and transport properties

360

pH Dependence of reactive sites of curcumin possessing antioxidant activity and free radical scavenging ability studied using the electrochemical and ESR techniques: Polyaniline used as a source of the free radical

361

pH dependence of steroid hormone—organic matter interactions at environmental concentrations Original Research Article

362

pH dependence of tailing in reversed-phase chromatography of a cationic dye: measurement of the strong adsorption site surface density

363

pH dependence of the absorption and emission behaviour of lumiflavin in aqueous solution

364

pH dependence of the composition and stability of MnIII–bicarbonate complexes and its implication for redox interaction of MnII with photosystem II

365

pH dependence of the dissociation of multimeric hemoglobin probed by high hydrostatic pressure Original Research Article

366

pH dependence of the fluorescence lifetime of enhanced yellow fluorescent protein in solution and cells

367

pH Dependence of the Folding of Intestinal Fatty Acid Binding Protein

368

pH dependence of the hydrophobicity of β-blocker amine compounds measured by counter-current chromatography

369

pH Dependence of the rate of DNA alkylation for (+)-duocarmycin SA and (+)-CCBI-TMI

370

pH Dependence of the Reaction Rate ofp-Bromophenacyl Bromide and of the Binding Constants of Ca2+and an Amide-Type Substrate Analog to Bovine Pancreatic Phospholipase A2

371

pH dependence of the reactions of arsenazo III with the lanthanides

372

pH dependency of ligand binding to cellobiohydrolase 1 (Cel7A): Affinity, selectivity and inhibition for designed propranolol analogues

373

pH dependency of serum ionised calcium Original Research Article

374

pH dependent binding of chlorin-p6 with phosphatidyl choline liposomes

375

pH Dependent binding of chlorin-p6 with phosphatidyl choline liposomes: Comparison between one and two-photon excited fluorescence

376

pH dependent conformational and structural changes of xylanase from an alkalophilic thermophilic Bacillus sp (NCIM 59)

377

pH dependent copper binding properties of a CuA azurin variant with both bridging cysteines replaced with serines

378

pH dependent dynamic behavior of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) in femtosecond to nanosecond time scale

379

pH dependent fluorescence switching in salicylideneaniline: ‘off–on–off’ operation controlled by surfactant micelles

380

pH Dependent formations of dinuclear molybdenum(V) and incomplete cubane molybdenum(IV) complexes with nitrilotriacetate

381

pH dependent growth of poly(L-lysine)/poly(L-glutamic) acid multilayer films and their cell adhesion properties

382

pH dependent interaction of biofunctionalized CdS nanoparticles with nucleobases and nucleotides: A fluorimetric study

383

pH dependent phosphate hydrolysis by a lanthanide EF-hand peptide

384

pH Dependent photophysics and role of medium on photoinduced electron transfer between ruthenium polypyridyl complex and anthraquinone

385

pH dependent protein stability: A quantitative approach based on Kramerʹs barrier escape

386

pH dependent reversible aggregation of Chitosan and glycol-Chitosan stabilized silver nanoparticles

387

pH dependent self assembly of (beta)-amyloid(10-35) and (beta)amyloid(10-35)-PEG3000

388

pH Dependent self-assembly of dimetallic lanthanide complexes

389

pH Dependent structural diversity of lead compounds based on new flexible ligand [3-(2-pyridyl)-1-pyrazolyl] acetic acid

390

pH dependent surface enhanced Raman study of Phe + Ag complex and DFT calculations for spectral analysis

391

pH dependent uptake of porphyrin-type photosensitizers by solid tumor cells in vitro is not induced by modification of transmembrane potential

392

PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt

393

PH effect in the photocatalytic transformation of a phenyi-urea herbicide

394

pH effect on cysteine and cystine behaviour at hanging mercury drop electrode

395

pH effect on OH radical production in photo/ferrioxalate system

396

pH Effect on the binding of chlorin derivatives with Cremophor EL, a potential drug delivery vehicle

397

pH effect on the electrochemical redox reaction of disulfide with polyaniline film electrode in organic solution

398

pH Effect on the Size of Graphene Quantum dot Synthesized by Using Pulse Laser Irradiation

399

pH Effect on the spectroscopic behavior and photoinduced generation of semiquinone anion radical of hypocrellin B

400

pH effects on collagen fibrillogenesis in vitro: Electrostatic interactions and phosphate binding

401

pH effects on drug interactions with lipid bilayers by liposome electrokinetic chromatography

402

pH effects on optical and DNA binding properties of a thiophene-containing ruthenium(II) complex

403

pH effects on the adherence and fouling propensity of extracellular polymeric substances in a membrane bioreactor

404

pH effects on the binding of oxygen to non-vertebrate monomeric hemoglobins. A linked function model.

405

pH effects on the cellular uptake of four photosensitizing drugs evaluated for use in photodynamic therapy of cancer

406

pH effects on the hyaluronan hydrolysis catalysed by hyaluronidase in the presence of proteins. Part III. The electrostatic non-specific hyaluronan–hyaluronidase complex

407

pH effects on the hyaluronan hydrolysis catalysed by hyaluronidase in the presence of proteins: Part II. The electrostatic hyaluronan – Protein complexes

408

pH effects on the second-order nonlinear optical properties of surface modified CdS nanoparticles

409

pH evolution in sea ice grown at an outdoor experimental facility

410

P–H functionalised phosphinoalkoxides as ligands: synthesis and catalytic properties of [Cp2Zr(Me)(cyclo-1-O-2-PH(Tipp)-C6H10)] (Tipp=2,4,6-Pri3C6H2), [Cp2Zr(Me)(cyclo-1-O-2-PH(Tipp){Mo(CO)5}–C6H10)] and [Cp2Zr(BH4)(cyclo-1-O-2-PH(Mes)(BH3)–C6H10)] (Mes=2

411

pH gradient high-performance liquid chromatography: theory and applications

412

pH gradient reversed-phase liquid chromatography as a fractionation tool for the separation of peptides

413

pH has a role in cystic fibrosis infections

414

pH Heterogeneity of human and rabbit atherosclerotic plaques; a new insight into detection of vulnerable plaque

415

pH HOMEOSTASIS OF THE CIRCADIAN SPORULATION RHYTHM IN CLOCK MUTANTS OF NEUROSPORA CRASSA

416

pH Independent Complexation of 2-Aminobenzimidazole with β-cyclodextrin

417

pH indications in aqueous organic photodecompositions with carbonyl and hydroxyl groups

418

pH Induced Aggregation and Weak Gel Formation of Whey Protein Polymers

419

pH influence on root growth and nutrient uptake of Pinus pinaster seedlings

420

pH influence on sorption characteristics of heavy metal in the vadose zone

421

pH Influence on the stability of foams with protein–polysaccharide complexes at their interfaces

422

pH is a good predictor of the distribution of anoxygenic purple phototrophic bacteria in Arctic soils

423

pH is a good predictor of the distribution of anoxygenic purple phototrophic bacteria in Arctic soils

424

pH measurement and control in solvent extraction using column contractors

425

pH MEASUREMENT USING MICRO GAP STRUCTURE

426

pH Metric, Spectroscopic and Thermodynamic Study of Complexation Behavior of 2-aminobenzothiazole with Ni (II) in Presence of Amino Acids

427

pH microelectrode–micropipette system for the measurement of enzyme reactions in a picoliter volume of a living plant cell Original Research Article

428

pH modelling by neural networks. Application of control and validation data series in the Middle Loire river

429

pH modelling by neural networks. Application of control and validation data series in the Middle Loire river

430

pH Modulates the Quinone Position in the Photosynthetic Reaction Center from Rhodobacter sphaeroides in the Neutral and Charge Separated States

431

pH modulation of transport properties of alamethicin oligomers inserted in zwitterionic-based artificial lipid membranes Original Research Article

432

pH neutralization and influence on mechanical strength in self-adhesive resin luting agents

433

pH of activated carbon surface as an indication of its suitability for H2S removal from moist air streams Original Research Article

434

435

pH of soul: How does acid-base balance affect our cognition?

436

pH of the Martian surface

437

pH optical sensors based on sol–gels: Chemical doping versus covalent immobilization Original Research Article

438

pH Oscillations and complex reaction dynamics in the non-buffered chlorite–thiourea reaction

439

pH polymeric membrane microelectrodes based on neutral carriers and their application in aquatic environments Original Research Article

440

pH pre-corrected liquid hot water pretreatment on corn stover with high hemicellulose recovery and low inhibitors formation

441

pH programming in capillary electrophoresis by means of temperature programming

442

pH regulates key players of nitrification in paddy soils

443

pH regulates key players of nitrification in paddy soils

444

pH regulation as a method of intensification of soil electroremediation

445

pH regulation during ischaemia-reperfusion of isolated rat hearts, and metabolic effects of 2,3-butanedione monoxime

446

pH Regulation in Anoxic Plants

447

pH regulation of alkaline wastewater with carbon dioxide: A case study of treatment of brewery wastewater in UASB reactor coupled with absorber

448

pH regulation of carbon and nitrogen dynamics in two agricultural soils

449

pH regulation of carbon and nitrogen dynamics in two agricultural soils

450

pH responsive “off–on–off” luminescent switch of a novel ruthenium(II) complex [Ru(bpy)2(pipipH2)]2+

451

pH responsive cross-linked polymeric matrices based on natural polymers: effect of process variables on swelling characterization and drug delivery properties

452

pH responsive itaconic acid grafted alginate microspheres for the controlled release of nifedipine

453

pH responsive luminescent switches of ruthenium(II) complexes containing two imidazole groups: Synthesis, spectroscopy, electrochemistry and theoretical calculations

454

pH Responsive micelle self-assembled from a new amphiphilic peptide as anti-tumor drug carrier

455

pH responsiveness of two-layer nano-composite membrane with ultrathin cylindrical nanopores PS-b-P4VP film

456

pH sensing in living cells using fluorescent microspheres

457

pH sensitive halloysite-sodium hyaluronate/poly(hydroxyethyl methacrylate) nanocomposites for colon cancer drug delivery

458

pH Sensitive Hydrogel Based Acrylic Acid for Controlled Drug Release

459

pH Sensitive Hydrogel Based on Poly(Acrylic Acid) and Cellulose Nanocrystals

460

pH sensitive N-succinyl chitosan grafted polyacrylamide hydrogel for oral insulin delivery

461

pH sensitive photoconductor based on poly(para-phenylene-vinylene)

462

pH sensitive photoconductor based on poly(para-phenylene-vinylene)

463

pH Sensitive polypropylene porous membrane prepared by grafting acrylic acid in supercritical carbon dioxide

464

pH sensitive silica nanotubes as rationally designed vehicles for NSAIDs delivery

465

pH Sensitive supramolecular assembling system between a new linear water soluble β-cyclodextrin terpolymer and an amphiphilic poly(ethylene oxide)

466

pH sensitivity of polyaniline and its substituted derivatives

467

pH sensor based on a detection sol–gel layer onto optical fiber

468

pH sensor based on deposited film of lead oxide on aluminum substrate electrode

469

pH sensor based on the crown heteropolyanion K28Li5H7P8W48O184·92H2O immobilized using a layer by layer assembly process

470

pH sensors with lithium lanthanum titanate sensitive material: applications in food industry

471

pH sequential ozonation of domestic and wine-distillery wastewaters

472

pH simulation model in a mixed layer of a lacustrine environment (the case of Lake Orta)

473

pH simulation model in a mixed layer of a lacustrine environment (the case of Lake Orta)

474

pH stress can cause cell elongation in Bacillus and Clostridium species: a research note

475

pH Switched sensitisation of europium(III) by a dansyl group

476

pH switching on-off semi-IPN hydrogel based on cross-linked poly(acrylamide-co-acrylic acid) and linear polyallyamine

477

pH transients in hydroxyapatite chromatography columns—Effects of operating conditions and media properties

478

pH Transients in hydroxyapatite chromatography columns—Experimental evidence and phenomenological modeling

479

pH transitions in cation exchange chromatographic columns containing weak acid groups

480

pH Transitions in Ion-Exchange Systems: Role in the Development of a Cation-Exchange Process for a Recombinant Protein

481

pH triggered release of protective poly(ethylene glycol)-b-polycation copolymers from liposomes

482

pH tunable morphology of the gold nanoparticles produced by citrate reduction

483

pH value and ionic strength effects on the adsorption kinetics of protein/phospholipid at the chloroform/water interface

484

pH Value controlled structures: from macrocyclic complex monomer to 2D macrocyclic sheet

485

pH value dependence of the photothermal and optical absorption spectra for polyaniline films

486

pH variability and CO2 induced acidification in the North Sea

487

pH, alkalinity and total CO2 in coastal seawater by potentiometric titration with a difference derivative readout Original Research Article

488

pH, Dissolved Oxygen, and Adsorption Effects on Metal Removal in Anaerobic Bioreactors

489

pH, Photo, and Aeration Period Effects on Arthrospira maxima Growth: Taguchi Technique

490

pH, serum proteins and ionic strength influence the uptake of merocyanine 540 by WiDr cells and its interaction with membrane structures

491

Ph.D. in Business Management at Istanbul University: A New Programme in English Ready to Commence in Fall 2016

492

Ph.D. in Nursing from Theory to Reality

493

Ph.D. Students of Irving Segal

494

pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate

495

pH/Temperature control of interpolymer complexation between poly(acrylic acid) and weak polybases in aqueous solutions

496

pH/temperature sensitive poly(ethylene glycol)-based biodegradable polyester block copolymer hydrogels

497

pH/temperature-responsive behaviors of semi-IPN and comb-type graft hydrogels composed of alginate and poly(N-isopropylacrylamide)

498

pH/temperature-sensitive 4-arm poly(ethylene glycol)-poly(amino urethane) copolymer hydrogels

499

Ph[PhC(O)NH]2PyNC(O)Ph: a new mesomeric stabilized azaylide. Synthesis, crystal structure and IR spectroscopic results

500

Ph[PhC(O)NH]2PyNC(O)Ph: a new mesomeric stabilized azaylide. Synthesis, crystal structure and IR spectroscopic results

501

Ph3BiCO3: a mild reagent for in situ oxidation of urazoles to triazolinediones

502

Ph3P/Br2/n-Bu4NNO2 as an efficient system for the preparation of N-nitrosamines and azides

503

PHA based denitrification: Municipal wastewater vs. acetate

504

PHA immune response assay in captive zebra finches is modulated by activity prior to testing

505

PHA production by mixed cultures: A way to valorize wastes from pulp industry

506

PHA production from wastewater by mixed microbial culture under short-term microbial enrichment

507

PHA stimulation may be useful for FDXR gene expression-based biodosimetry

508

PHA/IL2: An Efficient Mitogen Cocktail for Cytogenetic Studies of Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

509

PHA: A fast potential-based hierarchical agglomerative clustering method

510

PHAC SYNTHASES AND PHA DEPOLYMERASES: THE ENZYMES THAT PRODUCE AND DEGRADE PLASTIC

511

PHACE(S) syndrome: Report of a case with new ocular and systemic manifestations

512

PHACES (Photographs of Academic Clinicians and Their Educational Status): A Tool to Improve Delivery of Family-Centered Care

513

PHACES syndrome with cataract and Horner’s syndrome: a case report

514

Phaco chop: Matering technique, optimizing technology, and avoiding complication

515

Phacodynamic: An Apiration Flow v Vacuum Comparion

516

Phacodynamic: Matering the Tool and Technique of Phacoemulification urgery; Fourth Edition

517

Phacoemulification and len implantation after cleral buckling urgery

518

Phacoemulification Aociated Corneal Damage Evaluated by Corneal Volume

519

Phacoemulification cataract extraction and poterior chamber len implantation in patient with uveiti

520

Phacoemulification of Cataract in Patient Receiving Coumadin Therapy: Ocular and Hematologic Rik Aement Original Reearch Article

521

Phacoemulification v mall-Inciion Manual Cataract urgery: An Expert Trial

522

Phacoemulsification of bilateral cataracts in two pet rabbits

523

Phacomorphic Glaucoma as the First Manifestation of the Choroidal Malignant Melanoma

524

Phacotrabeculectomy and Implantation of Intraocular Lenses with Releasable Sutures and Antimetabolite Agents: Efficacy and Safety

525

Phacotrabeculectomy With Mitomycin C in Patient With Uveiti

526

Phae I/II randomized trial of intrahepatic arterial infuion chemotherapy with ciplatin and chemoembolization with ciplatin and polyvinyl ponge in patient with ocular melanoma metatatic to the liver

527

Phaehyphomycosis caused by Veronea bothryosa

528

Phaeoacremonium tuscanicum, a new fungal pathogen associated with oak decline in Zagros forests, Iran

529

Phaeochromocytoma

530

Phaeochromocytoma—views on current management

531

Phaeocystis blooms in the global ocean and their controlling mechanisms: a review

532

Phaeohyphomycosis caused by Diaporthe phaseolorum in an immunocompetent patient in Thailand: a case report

533

Phaeomoniella chlamydospora: causal agent of vine decline (Vitis vinifera) in the vineyards of Slovakia

534

Phaeophytins from Gossypium mustelinum Miers ex Watt (Malvaceae)

535

Phage adsorption to Lactobacillus plantarum: Influence of physiological and environmental factors

536

Phage coated magnetoelastic micro-biosensors for real-time detection of Bacillus anthracis spores

537

Phage Display and Crystallographic Analysis Reveals Potential Substrate/Binding Site Interactions in the Protein Secretion Chaperone CsaA from Agrobacterium tumefaciens

538

Phage display as a tool for the directed evolution of enzymes

539

Phage display combinatorial libraries of short peptides: ligand selection for protein purification

540

Phage display identifies an Eastern equine encephalitis virus glycoprotein E2-specific B cell epitope

541

Phage display identifies an Eastern equine encephalitis virus glycoprotein E2-specific B cell epitope

542

Phage display of functional, full-length human and viral membrane proteins

543

Phage Display Reveals Multiple Contact Sites between FhuA, an Outer Membrane Receptor of Escherichia coli, and TonB

544

Phage Display Screening Reveals an Association Between Germline-specific Transcription Factor Oct-4 and Multiple Cellular Proteins

545

Phage display selection and characterization of single-chain recombinant antibodies against Eimeria tenella sporozoites

546

Phage display selection and characterization of single-chain recombinant antibodies against Eimeria tenella sporozoites

547

Phage display techniques to obtain antibodies against turbot (Scophthalmus maximus) blood cells

548

Phage display technology for stem cell delivery and systemic therapy

549

Phage display technology: clinical applications and recent innovations

550

Phage FR38 Treatment on Sprague Dawley Rat Inferred from Blood Parameters and Organ Systems

551

Phage Genomics: Small Is Beautiful

552

Phage inactivation of foodborne pathogens on cooked and raw meat

553

Phage inactivation of Staphylococcus aureus in fresh and hard-type cheeses

554

Phage Integrases: Biology and Applications Review Article

555

Phage Langmuir monolayers and Langmuir–Blodgett films

556

Phage Like It HOT: Solution Structure of the Bacteriophage P1-Encoded HOT Protein, a Homolog of the θ Subunit of E. coli DNA Polymerase III

557

Phage ø29 DNA polymerase residues involved in the proper stabilisation of the primer-terminus at the 3′-5′ exonuclease active site

558

Phage P22 Procapsids Equilibrate with Free Coat Protein Subunits

559

Phage Peptide Libraries As a Source of Targeted Ligands

560

Phage selection for site-specific incorporation of unnatural amino acids into proteins in vivo Original Research Article

561

Phage Therapy in COVID-19 Treatment

562

Phage therapy: A modern tool to control bacterial infections

563

Phage therapy: assessment of the efficacy of a bacteriophage isolated in the treatment of salmonellosis induced by Salmonella enteritidis in mice

564

Phage therapy—advantages over antibiotics?

565

Phage Types of multidrug resistant Salmonella species in a rural area of Maharashtra, India

566

Phage types, virulence genes and PFGE profiles of Shiga toxin-producing Escherichia coli O157:H7 isolated from raw beef, soft cheese and vegetables in Lima (Peru)

567

Phage typing combined with pulsed-field gel electrophoresis and random amplified polymorphic DNA increases discrimination in the epidemiological analysis of Salmonella enteritidis strains

568

Phage typing, PCR amplification for mecA gene, and antibiotic resistance patterns as epidemiologic markers in nosocomial outbreaks of methicillin resistant Staphylococcus aureus

569

Phage versus Phagemid Libraries for Generation of Human Monoclonal Antibodies

570

Phage λ takes the first exit

571

Phage-based nanomaterials for biomedical applications

572

Phage-borne peptidomimetics as immunochemical reagent in dot-immunoassay for mycotoxin zearalenone

573

Phage-displayed Antibody Libraries of Synthetic Heavy Chain Complementarity Determining Regions

574

Phage-displayed peptide library screening for preferred human substrate peptide sequences for transglutaminase 7

575

Phage-displayed peptides that mimic zearalenone and its application in immunoassay

576

Phage-displayed protein chip based on SPR sensing

577

Phagemid Vectors for Phage Display: Properties, Characteristics and Construction Review Article

578

Phage-peptide Display Identifies the Interferon-responsive, Death-activated Protein Kinase Family as a Novel Modifier of MDM2 and p21WAF1

579

Phage-related DNA polymorphism in dairy and probiotic Lactobacillus

580

Phage-resistance linked to cell heterogeneity in the commercial strain Lactobacillus delbrueckii subsp. lactis Ab1

581

Phage-resistant mutants of Lactobacillus delbrueckii may have functional properties that differ from those of parent strains

582

Phagocyte functions in stressed rats: comparison of modulation by glutamine, arginine and ornithine 2-oxoglutarate

583

Phagocyte implications in advanced atherosclerosis

584

Phagocyte-derived S100 proteins in autoinflammation: Putative role in pathogenesis and usefulness as biomarkers

585

Phagocyte-Generated Superoxide Reduces Fe3+ to Displace It from the Surface of Asbestos

586

Phagocyte-induced lipid peroxidation of different intravenous fat emulsions and counteractive effect of vitamin E

587

Phagocyte–myocyte interactions and consequences during hypoxic wound healing

588

Phagocytes and oxidative stress

589

Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules

590

Phagocytic Activity and IL-1 Alpha Levels for Asthma Patients

591

Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent

592

Phagocytic Activity of Patients with a Diabetic Foot in Wasit Province, Iraq

593

Phagocytic activity of scallop (Pecten maximus) haemocytes maintained in vitro

594

Phagocytic activity of turbot (Scophthalmus maximus) leucocytes: opsonic effect of antibody and complement

595

Phagocytic activity of two lines of chickens divergently selected for antibody production

596

Phagocytic activity of two lines of chickens divergently selected for antibody production

597

Phagocytic and chemotactic responses of manila and carpet shell clam haemocytes against Vibrio tapetis, the causative agent of brown ring disease

598

Phagocytic and Metabolic Activities of Macrophages from Mummichog Naturally Exposed to Pulp Mill Effluents in the Miramichi River

599

Phagocytic capacity and apoptosis of peripheral blood cells from patients with iron deficiency anemia

600

Phagocytic cells of the thymic reticulum interact with thymocytes via extracellular matrix ligands and receptors

601

Phagocytic function and metabolite production in thioacetamide-induced liver cirrhosis: a comparative study in perfused livers and cultured Kupffer cells

602

Phagocytic killing of microorganisms by radical processes:consequences of the reaction of hydroxyl radicals with chloride yielding chlorine atoms

603

Phagocytic response of macrophages from the pronephros of American plaice (Hipoglossoides platessoides) exposed to contaminated sediments from Baie des Anglais, Quebec

604

Phagocytic Response of Terrestrial and Aquatic Invertebrates Following in Vitro Exposure to Trace Elements

605

Phagocytosis and development: back to the future

606

Phagocytosis and innate immunity

607

Phagocytosis and respiratory burst activity of haemocytes from the ivory snail, Babylonia areolata

608

Phagocytosis by B-cells and neutrophils in Atlantic salmon (Salmo salar L.) and Atlantic cod (Gadus morhua L.)

609

Phagocytosis in pup and adult harbour, grey and harp seals

610

Phagocytosis in pup and adult harbour, grey and harp seals

611

Phagocytosis inhibition of clam and mussel haemocytes by Perkinsus atlanticus secretion products.

612

Phagocytosis of Candida albicans by concanavalin-A activated peritoneal macrophages

613

Phagocytosis of Candida albicans by concanavalin-A activated peritoneal macrophages

614

Phagocytosis of candida albicans by lymphatic tumour cells in vitro

615

Phagocytosis of Candida albicans by metastatic and non metastatic human breast cancer cell lines in vitro

616

Phagocytosis of chemically modified carbon materials

617

Phagocytosis of Loma salmonae (Microsporidia) spores in Atlantic salmon (Salmo salar), a resistant host, and chinook salmon (Oncorhynchus tshawytscha), a susceptible host

618

Phagocytosis of N-acetyl-d-glucosamine particles, a Th1 adjuvant, by RAW 264.7 cells results in MAPK activation and TNF-α, but not IL-10, production

619

Phagocytosis of wear debris by osteoblasts affects differentiation and local factor production in a manner dependent on particle composition

620

Phagocytosis, endosomal/lysosomal system and other cellularaspects of macrophage activation by Canova medication

621

Phagocytotic removal of apoptotic endocrine cells by folliculostellate cells and its functional implications in clusterin accumulation in pituitary colloids in helmeted guinea fowl (Numida meleagris)

622

Phagostimulatory effect of uptake of PLGA microspheres loaded with rifampicin on alveolar macrophages

623

Phagotrophic algae in a wastewater stabilization pond

624

PHAHs in 14 principal river sediments from Hai River basin, China Original Research Article

625

Phakic Intraocular Lenses and their Special Indications

626

Phakic IOL: A photo finih?

627

Phakic poterior chamber intraocular len for the correction of aniometropia and treatment of amblyopia

628

Phakomatosis pigmentovascularis type IIa

629

Phalangeal osteochondroma: a cause of childhood trigger finger

630

Phalangeal osteosonogrammetry age-related changes and assessment of a Lebanese reference population

631

Phalangeal Tuberculosis After Mallet Finger Treatment: A Case Report

632

Phalangeal ultrasonography in forearm fracture discrimination

633

Phalanx-like osseous structure posterior to the cervical vertebrae: a hitherto unreported location for a rare anomaly

634

Phalaropes feeding at a coastal front in Santa Monica Bay, California

635

PHALEN TEST POSITIVATION TIME an‎d ITS CORRELATION WITH ELECTRONEUROMYOGRAPHY

636

Phallometric testing with sexual offenders: Limits to its value

637

Phalloplasty for an amputated phallus in intersex patients

638

Phalloplasty in female-to-male transsexuals using free radial osteocutaneous flap: a series of 22 cases, ,

639

Phanerochaete chrysosporium pretreatment of biomass to enhance solvent production in subsequent bacterial solid-substrate cultivation

640

Phanerochaete flavido-alba ligninolytic activities and decolorization of partially bio-depurated paper mill wastes

641

Phanerozoic atmospheric CO2 change: evaluating geochemical and paleobiological approaches

642

Phanerozoic biodiversity: rocks or real?

643

Phanerozoic burial and unroofing history of the western Slave craton and Wopmay orogen from apatite (U–Th)/He thermochronometry

644

Phanerozoic changes in the high-rank suprageneric diversity structure of brachiopods: Linear and non-linear effects

645

Phanerozoic continental growth and gold metallogeny of Asia

646

Phanerozoic Continental Growth of East and Southeast Asia: Timings of Amalgamation and Accretion

647

Phanerozoic Geodynamic Evolution of the Circum-Italian Realm

648

Phanerozoic high-pressure eclogite and intermediate-pressure granulite facies metamorphism in the Gyeonggi Massif, South Korea: Implications for the eastward extension of the Dabie–Sulu continental collision zone

649

Phanerozoic hot spot traces and paleogeographic reconstructions of the Siberian continent based on interaction with the African large low shear velocity province

650

Phanerozoic Large Igneous Provinces (LIPs), HEATT (Haline Euxinic Acidic Thermal Transgression) episodes, and mass extinctions

651

Phanerozoic marine biodiversity follows a hyperbolic trend

652

Phanerozoic organic-carbon-rich marine sediments: Overview and future research challenges

653

Phanerozoic paleogeography, paleoenvironment and lithofacies maps of the circum-Atlantic margins

654

Phanerozoic polar wander, palaeogeography and dynamics

655

Phanerozoic reactivation along a fundamental Proterozoic crustal fault, the Darling River Lineament, Australia: constraints from apatite fission track thermochronology

656

Phanerozoic reactivation of the Archean North China Craton through episodic magmatism: Evidence from zircon U–Pb geochronology and Hf isotopes from the Liaodong Peninsula

657

Phanerozoic Reconstitution of Indian Shield as Aftermath of Gondwana Break-up

658

Phanerozoic tectonics of the South China Block: Key observations and controversies

659

Phanerozoic tectonothermal events of the Xuefengshan Belt, central South China: Implications from UPb age and LuHf determinations of granites

660

Phanerozoic, pre-Cretaceous thermotectonic events in southern Sweden revealed by fission track thermochronology

661

Phanerozoic, pre-Cretaceous thermotectonic events in southern Sweden revealed by fission track thermochronology

662

Phanquinone: a useful fluorescent pre-chromatographic derivatization reagent for liquid chromatographic analyses of amino acid dosage forms Original Research Article

663

PHANTASTICA Regulates Development of the Adaxial Mesophyll in Nicotiana Leaves

664

Phantom accretion by black holes and the generalized second law of thermodynamics

665

Phantom and in vivo study of the look–locher T1 mapping method

666

Phantom Archean crust in Mangaia hotspot lavas and the meaning of heterogeneous mantle

667

Phantom bursting is highly sensitive to noise and unlikely to account for slow bursting in -cells: Considerations in favor of metabolically driven oscillations

668

Phantom dosimeters examined by NMR analysis: a promising technique for 3-D determination of absorbed dose

669

Phantom elasticity reconstruction with Digital Image Elasto-Tomography

670

Phantom endometriosis of the sciatic nerve

671

Phantom evolution in power-law potentials Original Research Article

672

Phantom faces for face analysis

673

Phantom feelings in the thalamus explained

674

Phantom Friedmann cosmologies and higher-order characteristics of expansion

675

Phantom limb after stroke: An underreported phenomenon

676

Phantom limb pain

677

Phantom limb pain

678

Phantom limb pain in pediatric burn survivors

679

Phantom Limb Sensation (PLS) and Phantom Limb Pain (PLP) among Young Landmine Amputees

680

PHANTOM LIMB SYNDROME: A REVIEW

681

Phantom limbs – Or phantoms of phantom limbs?

682

Phantom maps and homology theories

683

Phantom Maps and Purity in Modular Representation Theory, III

684

Phantom maps and the Gray index

685

Phantom Maps in the Stable Module Category

686

Phantom materials for single point imaging pulse sequences

687

Phantom nurses at real bedsides

688

689

Phantom reflexes: Muscle contractions at a frequency not physically present in the input stimuli

690

Phantom study of radiotracer concentration quantification in breast scintigraphy

691

Phantom thermodynamics Original Research Article

692

Phantom tumor of the lung in heart failure patient

693

Phantom Validation of Tc-99m Absolute Quantification in a SPECT/CT Commercial Device

694

PHANTOM: A Monte Carlo event generator for six parton final states at high energy colliders Original Research Article

695

Phantom: a simple and effective flow control scheme

696

Phantom-based performance evaluation: Application to brain segmentation from magnetic resonance images

697

Phantom-like behaviour in dilatonic brane-world scenario with induced gravity Original Research Article

698

Phantom-limb lengthening after heart transplant

699

Phantom-limb pain: characteristics, causes, and treatment

700

Phantom-node method for shell models with arbitrary cracks

701

Phantoms and spectres: capital and labour at the millennium

702

Phantoms of regularity in the sea of quantum chaos

703

PhAP protease from Pseudoalteromonas haloplanktis TAC125: Gene cloning, recombinant production in E. coli and enzyme characterization

704

Phar Lap and duodenitis-proximal jejunitis

705

Pharaoh and the Divine Wont of Respiting: A Critical Analysis of Quranic Themes

706

PHARAOH EAGLE-OWL BUBO ASCALAPHUS (SAVIGNY, 1809) (STRIGIFORMES, STRIGIDAE), THE “SHROUDED IN MYSTERY” OWL OF IRAQ an‎d IRAN

707

Pharmaceutical Advances and Proteomics Researches

708

Pharmaceutical advertising versus research spending: are profits more important than patients?

709

Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues

710

Pharmaceutical Analysis, D.C. Lee, M. Webb (Eds.). Blackwell Publishing Ltd, Oxford, UK (2003)

711

Pharmaceutical and Bio-analytical Applications of Ion Mobility Spectrometry for Determination of Clopidogrel (Plavix)

712

Pharmaceutical and biotechnological aerosols for cystic fibrosis therapy

713

Pharmaceutical and clinical aspects of p-phenylene-diamine patch test material

714

PHARMACEUTICAL AND CLINICAL EVALUATION OF INTRAVENOUS ADMIXTURE OF DOBUTAMINE AND DOPAMINE USED IN TREATMENT HYPOTENSION IN NEONATAL INTENSIVE CARE UNITS

715

Pharmaceutical and industrial protein engineering: Where we are?

716

Pharmaceutical and nutraceutical effects of Pinus pinaster bark extract

717

Pharmaceutical and nutraceutical management of canine osteoarthritis: Present and future perspectives

718

Pharmaceutical and personal care products (PPCPs) in urban receiving waters l

719

Pharmaceutical and personal care products in tile drainage following surface spreading and injection of dewatered municipal biosolids to an agricultural field Original Research Article

720

Pharmaceutical and Related Drugs

721

Pharmaceutical applications of a flurbiprofen sensor

722

Pharmaceutical applications of calorimetric measurements in the new millennium

723

Pharmaceutical applications of confocal laser scanning microscopy: The physical characterisation of pharmaceutical systems

724

Pharmaceutical applications of dynamic mechanical thermal analysis

725

Pharmaceutical applications of embryonic stem cells

726

Pharmaceutical applications of isoelectric focusing on microchip with imaged UV detection

727

Pharmaceutical applications of magnetic resonance imaging (MRI)

728

Pharmaceutical applications of Mid-IR and Raman spectroscopy

729

Pharmaceutical applications of some spanish clays (sepiolite, palygorskite, bentonite): some preformulation studies

730

Pharmaceutical applications of various natural gums, mucilages and their modified forms

731

Pharmaceutical Approaches and Advancements in Male Contraception

732

Pharmaceutical aspects of parenteral nutrition: from now to the future

733

Pharmaceutical Care Approach to Hearing Loss

734

Pharmaceutical Care Education and Practice in Jordan in the New Millennium

735

Pharmaceutical care impact on health-related quality of life (HRQOL) and pharmaco-economical burden on COVID recovered diabetic patients with comorbid condition

736

Pharmaceutical Care Program for Patients With Uncontrolled Hypertension: Report of a Double-Blind Clinical Trial With Ambulatory Blood Pressure Monitoring

737

Pharmaceutical challenges in veterinary product development

738

Pharmaceutical Characterization and in vivo Evaluation of the Possible Anti-Inflammatory Effect of Topical Allopurinol Gel in an Animal Model

739

Pharmaceutical Characterization of Aqueous Stem Bark Extract of Bridelia ferruginea Benth (Euphorbiaceae)

740

Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment

741

Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation

742

Pharmaceutical Co-Crystallization: Regulatory Aspects, Design, Characterization, and Applications

743

Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development

744

Pharmaceutical companies and the third world

745

Pharmaceutical companies pay criminal fine for fxobal price fixing

746

Pharmaceutical companies pledge vaccines for developing countries

747

Pharmaceutical companies target plant products for drugs of the future

748

Pharmaceutical company trials and the integrity of medical research

749

Pharmaceutical Compounds as Photostabilizers

750

Pharmaceutical cost management and access to psychotropic drugs: The U.S. context

751

Pharmaceutical economy and the economic assessment of drugs in France

752

Pharmaceutical Electrochemistry: the Electrochemical Behaviour of Paracetamol at ZnO Nanoparticales/1, 2-Napthaquinone-4-Sulphonic Acid Glassy Carbon Modified Electrode

753

Pharmaceutical Equivalence of Some Commercial Samples of Artesunate and Amodiaquine Tablets Sold in Southwestern Nigeria

754

Pharmaceutical Evaluation of Metformin HCl Products Available in the Jordanian Market

755

Pharmaceutical Evaluation of Ziziphus Jujuba Mucoadhesive Buccal Film

756

Pharmaceutical Excipient Development: The Need for Preclinical Guidance

757

Pharmaceutical Formulation of Garlic and Turmeric Dried Crude Extract and Their Synergistic Antifungal Activity and Safety

758

Pharmaceutical haute couture: educating patients about health-care choices

759

Pharmaceutical impurities: Analytical, toxicological and regulatory perspectives

760

Pharmaceutical impurities: Regulatory perspective for Abbreviated New Drug Applications

761

Pharmaceutical industry profits and cost to senior citizensʹ health

762

Pharmaceutical Industry Roundtable Abstracts

763

Pharmaceutical innovation and longevity growth in 30 developing and high-income countries, 2000–2009

764

Pharmaceutical laws and regulations in Iran: An overview

765

Pharmaceutical microcalorimetry: recent advances in the study of solid state materials

766

Pharmaceutical Nanoemulsions and Their Potential Topical and Transdermal Applications

767

Pharmaceutical Nanoparticles and the Mucin Biopolymer Barrier

768

Pharmaceutical nanotechnology for oral delivery of anticancer drugs

769

Pharmaceutical Nickel(II) Chelation Properties of 3-Hydroxyflaven, Deferiprone and Maltol Metal Chelators: A Density Functional Study

770

Pharmaceutical patent analyst – FutureScience publishing

771

Pharmaceutical patents on plant derived materials in Brazil: Policy, law and statistics

772

Pharmaceutical policies used by private health insurance companies in Saudi Arabia

773

Pharmaceutical powder technology — from art to science: the challenge of the FDAʹs Process Analytical Technology initiative

774

Pharmaceutical powders analysis using FT-Raman spectrometry: Simultaneous determination of sulfathiazole and sulfanilamide

775

Pharmaceutical powders compaction: Experimental and numerical analysis of the density distribution

776

pharmaceutical prescription (Rx): Calcium, phosphate, and secundum artem

777

Pharmaceutical profiling method for lipophilicity and integrity using liquid chromatography–mass spectrometry

778

Pharmaceutical Properties of Hibiscus sabdariffa, Toward an Ideal Treatment for Hypertension

779

Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing

780

Pharmaceutical representatives

781

Pharmaceutical representatives’ beliefs and practices about their professional practice: a study in Sudan

782

Pharmaceutical Research in Wilhelmine Germany: The Case of E. Merck

783

Pharmaceutical research: paradox, challenge or dilemma?

784

Pharmaceutical risk management in Turkey: The first national overview

785

Pharmaceutical Statistics Using SAS®: A Practical Guide by Alex Dmitrienko, Christy Chuang-Stein, Ralph DʹAgostino

786

Pharmaceutical strategic purchasing requirements in Iran: Price interventions and the related effective factors

787

Pharmaceutical Strategic Purchasing: a Key to Improve Access to Medicines

788

Pharmaceutical supply chain risks: a systematic review

789

Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation

790

Pharmaceutical trace analysis in aqueous environmental matrices by liquid chromatography–ion trap tandem mass spectrometry

791

Pharmaceutical Wastewater Chemical Oxygen Demand Reduction: Electro-Fenton, UV-enhanced Electro-Fenton and Activated Sludge

792

Pharmaceutical wastewater treatment by membrane bioreactor process – a case study in southern Taiwan Original Research Article

793

Pharmaceutical workers

794

PHARMACEUTICAL, FOOD AND NON-FOOD APPLICATIONS OF MODIFIED STARCHES: A CRITICAL REVIEW

795

Pharmaceutical-enantiomers resolution using immobilized polysaccharide-based chiral stationary phases in supercritical fluid chromatography

796

Pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) in stormwater canals and Bayou St. John in New Orleans, Louisiana, USA

797

Pharmaceuticals and personal care products (PPCPs) in foods. Potential risks to human health?

798

Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada

799

Pharmaceuticals and personal care products (PPCPs) in treated wastewater discharges into Charleston Harbor, South Carolina Original Research Article

800

Pharmaceuticals and the Strategic National Stockpile Program

801

Pharmaceuticals in Australia: developments in regulation and governance

802

Pharmaceuticals in groundwaters: Analytical methods and results of a monitoring program in Baden-Württemberg, Germany

803

PHARMACEUTICALS IN IRAN: AN OVERVIEW

804

Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment

805

Pharmaceuticals in the aquatic environment––a comparison of risk assessment strategies

806

Pharmaceuticals in the river Elbe and its tributaries

807

Pharmaceuticals Safety Practices-A Comparative Pilot Study

808

Pharmaceuticals Solubility is Still Nowadays Widely Studied Everywhere

809

Pharmaceuticals, alkylphenols and pesticides in Mediterranean coastal waters: Results from a pilot survey using passive samplers

810

Pharmaceuticals, hormones and bisphenol A in untreated source and finished drinking water in Ontario, Canada — Occurrence and treatment efficiency Original Research Article

811

Pharmaceuticals, personal care products and endocrine-disrupting chemicals in U.S. surface and finished drinking waters: A proposed ranking system Original Research Article

812

Pharmaceuticals: a threat to drinking water? Original Research Article

813

Pharmaceuticals—our true clinical partners?

814

Pharmaciesʹ over-the-counter drug monopoly in Denmark ended

815

Pharmacies, self-medication and pharmaceutical marketing in Bombay, India

816

Pharmacist and nurse: a team approach towards primary health care or a convenient “therapeutic alliance”? Original Research Article

817

Pharmacist Interventions in Improving Clinical Outcomes in Patients with Type 2 Diabetes Mellitus Among the Underrepresented Population: A Collaborative Ambulatory Care Pharmacy Practice (CAPP) Approach

818

PHARMACIST ROLE IN GLOBAL HEALTH: A REVIEW OF LITERATURE

819

Pharmacist, the pharmaceutical industry and pharmacy education in Saudi Arabia: A questionnaire-based study

820

Pharmacist’s knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process

821

Pharmacist-Led Medication Review: Supports for New Role of Pharmacists

822

PHARMACIST-MANAGED THERAPEUTIC DRUG MONITORING SERVICE FOR ANTIEPILEPTIC DRUGS AND IMPROVED SEIZURE CONTROL

823

Pharmacist-Physician Organic Cooperation Is an Effective Strategy to Reduce the Medication-related Problems, An Experience in CKD Patients

824

Pharmacists agree: stop the pharmacy madness

825

Pharmacists as Entrepreneurs or Employees: The Role of Locus of Control

826

Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study

827

PHARMACISTS UNDERSTANDING AND ATTITUDES TOWARDS PHARMACEUTICAL CARE IN SAUDI ARABIA

828

Pharmacists’ and physicians’ perception and exposure to drug promotion: A Saudi study

829

Pharmacists’ Attitudes and Perceived Barriers about Community Pharmacy-Based Cardiovascular Risk Screening Services

830

PHARMACISTS’ NEGLIGENCE AND PRINCIPLES OF LIABILITY

831

Pharmacists’ Perception of the Sale of Non-Clinically Proven Health Supplements in Penang, Malaysia

832

Pharmaco1logic Evaluation of the Calcitonin Analogue SB 205614 in Models of Osteoclastic Bone Resorption In Vitro and In Vhro: Comparison With Salmon Calcitonin and Elcatonin

833

Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days

834

Pharmacodynamic and/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: An isobolographic analysis

835

Pharmacodynamic Effect of N-Acetylcysteine as Adjunctive Therapy in Mild Systemic Lupus Erythematosus Patients

836

Pharmacodynamic effects of milrinone with and without a bolus loading infusion

837

Pharmacodynamic Effects of Prasugrel Dosing Regimens in Patients on Maintenance Prasugrel Therapy: Results of a Prospective Randomized Study

838

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Patients With Stable Coronary Artery Disease: Results of the SWAP-2 Study (Switching Anti Platelet-2)

839

PHARMACODYNAMIC INTERACTION OF GARLIC WITH PROPRANOLOL IN ISCHEMIA-REPERFUSION INDUCED MYOCARDIAL DAMAGE

840

Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects Original Research Article

841

Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro

842

Pharmacodynamic profile of short-term readministration of abciximab in healthy subjects

843

Pharmacodynamic profile of the direct thrombin antagonist bivalirudin given in combination with the glycoprotein IIb/IIIa antagonist eptifibatide

844

Pharmacodynamic profiling of levofloxacin and gatifloxacin using Monte Carlo simulation for community-acquired isolates of Streptococcus pneumoniae

845

Pharmacodynamic study on acute hypotensive activities of Carissa carandas extract in normal rats

846

Pharmacodynamic–pharmacokinetic profiles of metformin hydrochloride from a mucoadhesive formulation of a polysaccharide with antidiabetic property in streptozotocin-induced diabetic rat models

847

Pharmacodynamics and microbiology of trovafloxacin in animal models of surgical infection

848

Pharmacodynamics and pharmacokinetics of cefoperazone and cefamandole in dogs following single dose intravenous and intramuscular administration

849

Pharmacodynamics and pharmacokinetics of flumequine in pigs after single intravenous and intramuscular administration

850

Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: Comparison with single and multiple daily doses of ilgrastim

851

Pharmacodynamics in the elderly

852

Pharmacodynamics of alpha2-adrenoceptor agonists

853

Pharmacodynamics of antimicrobial therapy in surgery

854

Pharmacodynamics of immunosuppressive drugs

855

Pharmacodynamics of Intermittent- and Continuous-Infusion Gefepime Alone and in Combination with Once-Daily Tobramycin against Pseudomonas aeruginosa in an in vitro Infection Model

856

Pharmacodynamics of mivacurium in severely burned patients

857

Pharmacodynamics of warfarin in cats

858

Pharmacodynamics Studies on Ricobendazole In Male Rats

859

Pharmacodynamics, safety, tolerability, and pharmacokinetics of the 0.8-mg dose of cerivastatin in patients with primary hypercholesterolemia

860

Pharmacodynamics: Relation to antimicrobial resistance

861

Pharmacodynamics: Relation to Antimicrobial Resistance

862

Pharmacoeconomic Aspects of Treating Hemorrhoidal Disease-Cost of Illness Study Based on Data from Balkan Country with Recent History of Social and Economic Transition

863

Pharmacoeconomic assessment of midazolam in two emergency departments

864

Pharmacoeconomic Education for Pharmacy Students in Bosnia and Herzegovina

865

Pharmacoeconomic Evaluation of Anti-Diabetic Therapy in A Nigerian Tertiary Health Institution

866

Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes

867

Pharmacoeconomic Impact Evaluation of Statin Adherence in High-risk Unselected Post Myocardial Infarction Population: an Administrative Database-guided Analysis

868

Pharmaco-economic issues for diabetes therapy

869

Pharmacoeconomic issues in antihypertensive therapy

870

Pharmacoeconomic study of antibiotics used in the treatment of lower respiratory tract infections in ICU patients: A case study in an Egyptian hospital

871

Pharmacoeconomics Analysis in a Pediatric Population

872

Pharmaco-economics analysis, as a strategy on facilitating choices between health and non-health programs in the establishment of the national health care system

873

Pharmacoeconomics and health outcomes: state of the art

874

Pharmacoeconomics and Utilization of Intravenous Iron Sucrose in a Tertiary Care Hospital

875

Pharmacoeconomics and Utilization of Intravenous Proton Pump Inhibitors in a Tertiary Care Hospital

876

Pharmacoeconomics for surgeons

877

Pharmacoeconomics in Iran: It Is Time to Take It into Practice

878

Pharmacoeconomics of Angiotensin Converting Enzyme Inhibitors in Heart Failure

879

PHARMACO-ECONOMICS OF MICRODOSING CLINICAL TRIALS IN DRUG DEVELOPMENT PROCESS

880

Pharmacoeconomics of pneumonia

881

Pharmacoeconomics: what is it and where is it going?

882

Pharmacoeconomics; an Appropriate Tool for Policy Makers or Just a New Field of Research in Iran?

883

Pharmaco-EEG-based assessment of interaction between ethanol and levetiracetam

884

Pharmacoepidemiological study of self-medication in adults attending pharmacies in Alexandria, Egypt

885

Pharmacoepidemiology of Drugs Used in Indoor Patients of Orthopaedic Department at a Tertiary Care Hospital

886

Pharmacoepidemiology Safety Study of Fibrate and Statin Concomitant Therapy

887

Pharmacogenetic Effect of Thiopurine Methyl Transferase (TPMT) Gene Expression and Serum TNF on the Imuran Response in Ulcerative Colitis (UC) Iraqi Patients

888

Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure Original Research Article

889

Pharmacogenetic prediction of clozapine response Original Research Article

890

Pharmacogenetic Studies of Depression

891

Pharmacogenetic Testing for Warfarin Dosing Still Awaits Validation

892

Pharmacogenetic variation of SLC47A1 gene and metformin response in type2 diabetes patients

893

Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450–metabolized drugs

894

Pharmacogenetics and adverse drug reactions

895

Pharmacogenetics and antipsychotic drugs

896

Pharmacogenetics and drug-induced nephrotoxicity in renal transplant recipients

897

Pharmacogenetics and future drug development and delivery

898

Pharmacogenetics and Personalized Medicine in Pancreatic Cancer

899

Pharmacogenetics draws an ACE

900

Pharmacogenetics in Cardiovascular Antithrombotic Therapy

901

Pharmacogenetics of anti-estrogen treatment of breast cancer

902

Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine

903

Pharmacogenetics of clozapine response

904

Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advances

905

Pharmacogenetics of disease-modifying anti-rheumatic drugs

906

Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management

907

Pharmacogenetics of inflammatory bowel disease

908

Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother

909

Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy

910

Pharmacogenetics, the Promise of Translating Personalized Medicine into Clinical Pediatrics

911

Pharmacogenetics: Fitting the Drug to the Patient

912

Pharmacogenetics: Is the right drug for the right patient sufficient?

913

Pharmacogenetics: Yeast Lead the Way

914

Pharmacogenetics-Oriented Therapeutic Drug Monitoring of Digoxin in Critically ILL Patients

915

Pharmacogenetics-Oriented Therapeutic Drug Monitoring of Digoxin in Critically ILL Patients

916

Pharmacogenomic approaches in the treatment of breast cancer by tamoxifen

917

Pharmacogenomic determination of genes associated with sensitivity or resistance of tumor cells to curcumin and curcumin derivatives

918

Pharmacogenomic profiling of an oxidative stress-mediated spongiform encephalopathy

919

Pharmacogenomic Profiling of the PI3K/PTEN Pathway in Sporadic Breast Cancer

920

Pharmacogenomics and -genetics in colorectal cancer

921

Pharmacogenomics and the Failing Heart: Are We Waiting for Godot?

922

Pharmacogenomics for Infectious Diseases

923

pharmacogenomics implementation and hurdles to overcome; in the context of a developing country

924

Pharmacogenomics in bladder cancer

925

Pharmacogenomics in bladder cancer

926

Pharmacogenomics in Cancer Chemotherapy

927

Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperone

928

Pharmacogenomics in non-small-cell lung cancer chemotherapy

929

Pharmacogenomics of organic anion-transporting polypeptides (OATP)

930

Pharmacogenomics- The Promise of Personalized Medicine

931

Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs

932

Pharmacogenomics: New paradigms for targeted therapy based on individual response to drugs

933

Pharmacogenomics: out of the lab and into the community

934

Pharmacognostic and Acute Toxicity Study of Burkea Africana Root

935

Pharmacognostic and AntiInflammatory Properties of Securigera securidaca Seeds and Seed Oil

936

Pharmacognostic and Elemental Analysis of the Leaves of Tapinanthus globifer (A. Rich). Tiegh

937

Pharmacognostic and Physico-chemical Investigation of Barleria cristata Linn. (Leaf) for Quality Control Assessment

938

Pharmacognostic and phytochemical investigation of Heracleum persicum Desf. ex Fischer

939

Pharmacognostic and Preliminary Phytochemical Investigation on Doronicum scorpioides Roots

940

Pharmacognostic Characteristics and Mutagenic Studies of Alstonia boonei De Wild

941

Pharmacognostic Characteristics of Hibiscus sabdariffa L. as a Means of Monitoring Quality

942

Pharmacognostic evaluation and physico-chemical analysis of Lantana camara (Linn.) flowers

943

Pharmacognostic evaluation of Achyranthes coynei: Leaf

944

Pharmacognostic Evaluation of Maesobotrya barteri (Baill) Hutch and Maesobotrya dusenii Pax (Euphorbiaceae) Leaves

945

Pharmacognostic Evaluation of Oxalis pes-caprae L. (Family Oxalidaceae)

946

Pharmacognostic evaluation of the leaves of Mitracarpus scaber Zucc (Rubiaceae)

947

Pharmacognostic Evaluation of the Leaves of Secamone afzelii (Schult) K Schum (Asclepiadaceae)

948

Pharmacognostic Investigation of the Leaves and Stems of Viburnum erubescens Wall.ex DC

949

Pharmacognostic Profile and Screening of Anti-Proliferative Potential of Methanolic Extract of Tripterygium wilfordii Plant on WRL-68 Cell Line and Function of Polycystin‐1

950

Pharmacognostic Standardization and Chromatographic Fingerprint Analysis on Triterpenoidal Constituents of the Medicinally Important Plant Artocarpus heterophyllus by High‑Performance Thin Layer Chromatography Technique

951

Pharmacognostic study of Argyreia pilosa stem

952

Pharmacognostic, Physicochemical and Phytochemical Investigations on Aerial Parts of Argemone mexicana L.

953

Pharmacognostical and physico-chemical evaluations of Cardiospermum halicacabum L. seeds

954

Pharmacognostical Sources of Popular Medicine To Treat Alzheimer’s Disease

955

Pharmacognostical study of Chorisia insignis HBK. grown in Egypt

956

Pharmacognostical, physico-chemical and contamination studies of polyherbal formulation “qurse pudina”

957

Pharmacokinetic analysis by high-performance liquid chromatography of intravenous nordihydroguaiaretic acid in the mouse

958

Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice

959

Pharmacokinetic analysis of ductal carcinoma in situ of the breast using dynamic MR mammography

960

Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging

961

Pharmacokinetic analysis of nicotine when using non-combustion inhaler type of tobacco product in Japanese adult male smokers

962

Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates

963

Pharmacokinetic and drug interaction studies of Pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan

964

Pharmacokinetic and excretion study of three secoiridoid glycosides and three flavonoid glycosides in rat by LC–MS/MS after oral administration of the Swertia pseudochinensis extract

965

Pharmacokinetic and fetal cardiovascular effects of enalaprilat administration to maternal rhesus macaques, ,

966

Pharmacokinetic and Hemodynamic Responses to Oral Sildenafil During Invasive Testing in Children With Pulmonary Hypertension

967

Pharmacokinetic and milk penetration of a difloxacin long-acting poloxamer gel formulation with carboxy-methylcellulose in lactating goats

968

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part 1. Absolute bioavailability of 0.25 mg of ganirelix after a single subcutaneous injection in healthy female volunteers

969

Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Doseproportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers

970

Pharmacokinetic and Pharmacodynamic Comparison of Controlled-Release Carvedilol and Immediate-Release Carvedilol at Steady State in Patients with Hypertension

971

Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida

972

Pharmacokinetic and pharmacodynamic modelling of marbofloxacin administered alone and in combination with tolfenamic acid in goats

973

Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation

974

Pharmacokinetic and pharmacodynamic properties of the new AEDs: A review article.

975

Pharmacokinetic and tissue distribution of doxycycline in broiler chickens pretreated with either: Diclazuril or halofuginone

976

Pharmacokinetic and toxicological data of spirolides after oral and intraperitoneal administration

977

Pharmacokinetic and tumour-photosensitizing properties of methoxyphenyl porphyrin derivative

978

Pharmacokinetic applicability of a validated liquid chromatography tandem mass spectroscopy method for orally administered curcumin loaded solid lipid nanoparticles to rats

979

Pharmacokinetic application of fuzzy structure identification and reasoning

980

Pharmacokinetic behavior and pharmacokinetic/pharmacodynamic integration of marbofloxacin after subcutaneous administration in goats

981

Pharmacokinetic behavior of marbofloxacin after intravenous, subcutaneous and intramuscular administrations in llamas (Lama glama)

982

Pharmacokinetic Behavior of Phenytoin in Head Trauma and Cerebrovascular Accident Patients in an Iranian Population

983

Pharmacokinetic Behavior of Theophylline following PEEP in Critically Ill Patients with Acute Lung Injury

984

Pharmacokinetic behaviour of ACP gel, an autocrosslinked hyaluronan derivative, after intraperitoneal administration

985

Pharmacokinetic behaviour of enrofloxacin in greater rheas following a single-dose intramuscular administration

986

Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs

987

Pharmacokinetic comparisons of different combinations of Shaoyao-Gancao-Decoction in rats: Simultaneous determination of ten active constituents by HPLC–MS/MS

988

Pharmacokinetic comparisons of puerarin, daidzin and the glucuronide metabolite of puerarin after administration of total flavonoid from Gegen alone and total flavonoid from Gegen combined with total saponin from Sanqi in rats under different physiologica

989

Pharmacokinetic Computer Simulations of the Relationship Between In Vivo and In Vitro Neuroreceptor Subtype Selectivity of Radioligands

990

Pharmacokinetic considerations for targeted drug delivery

991

Pharmacokinetic differences between ethnic groups

992

Pharmacokinetic differences between ethnic groups

993

Pharmacokinetic dosing of aminoglycosides: a controlled trial

994

Pharmacokinetic Drug Food Interaction Study of Nateglinide and Pomegranate Fruit Juice

995

Pharmacokinetic drug‑drug interaction and their implication in clinical management

996

Pharmacokinetic Effect of MDR Gene Polymorphism rs2032582 on the Therapeutic Response in Iraqi Patients with Acute Myeloid Leukemia

997

Pharmacokinetic enhancement of marbofloxacin by alpha-1-monolaurin pre-treatment in broiler chickens

998

PHARMACOKINETIC EVALUATION OF CLARITHROMYCIN ORAL CONTROLLED RELEASE MATRIX TABLETS FOR DESIRED BIOAVAILABILITY AND IMPROVED PATIENT COMPLIANCE

999

Pharmacokinetic evaluation of dipfluzine and its three metabolites in rat plasma using liquid chromatography–mass spectrometry

1000

Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug